AG2R LA Mondiale Gestion D Actifs Purchases 933 Shares of Humana Inc. $HUM

AG2R LA Mondiale Gestion D Actifs grew its position in shares of Humana Inc. (NYSE:HUM) by 17.2% during the 2nd quarter, Holdings Channel.com reports. The institutional investor owned 6,358 shares of the insurance provider’s stock after buying an additional 933 shares during the quarter. AG2R LA Mondiale Gestion D Actifs’ holdings in Humana were worth $1,554,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds have also recently modified their holdings of the company. Cary Street Partners Investment Advisory LLC lifted its position in shares of Humana by 63.9% during the 1st quarter. Cary Street Partners Investment Advisory LLC now owns 118 shares of the insurance provider’s stock worth $31,000 after buying an additional 46 shares in the last quarter. Zions Bancorporation National Association UT bought a new position in shares of Humana during the 1st quarter worth approximately $37,000. Ransom Advisory Ltd bought a new position in shares of Humana during the 1st quarter worth approximately $66,000. Transamerica Financial Advisors LLC lifted its position in shares of Humana by 1,027.6% during the 1st quarter. Transamerica Financial Advisors LLC now owns 327 shares of the insurance provider’s stock worth $87,000 after buying an additional 298 shares in the last quarter. Finally, Tower View Wealth Management LLC purchased a new stake in shares of Humana during the 2nd quarter worth approximately $88,000. Institutional investors own 92.38% of the company’s stock.

Wall Street Analysts Forecast Growth

HUM has been the subject of several research analyst reports. Barclays decreased their price target on shares of Humana from $315.00 to $245.00 and set an “equal weight” rating for the company in a research note on Friday, October 3rd. The Goldman Sachs Group initiated coverage on shares of Humana in a research note on Tuesday, October 14th. They set a “sell” rating and a $235.00 price target for the company. Mizuho raised their price target on shares of Humana from $300.00 to $345.00 and gave the stock an “outperform” rating in a research note on Thursday, October 9th. Truist Financial set a $300.00 price target on shares of Humana in a research note on Tuesday, October 14th. Finally, Royal Bank Of Canada raised their price target on shares of Humana from $283.00 to $322.00 and gave the stock an “outperform” rating in a research note on Thursday, August 21st. Eight equities research analysts have rated the stock with a Buy rating, ten have given a Hold rating and two have given a Sell rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Hold” and an average target price of $297.58.

Humana Stock Down 0.2%

Humana stock opened at $290.66 on Friday. Humana Inc. has a 1-year low of $206.87 and a 1-year high of $315.35. The firm has a market capitalization of $34.96 billion, a price-to-earnings ratio of 22.31, a P/E/G ratio of 1.70 and a beta of 0.42. The company has a current ratio of 1.95, a quick ratio of 1.95 and a debt-to-equity ratio of 0.69. The firm has a 50 day simple moving average of $281.65 and a 200 day simple moving average of $258.97.

Humana (NYSE:HUM) last released its quarterly earnings data on Wednesday, July 30th. The insurance provider reported $6.27 earnings per share for the quarter, missing analysts’ consensus estimates of $6.32 by ($0.05). Humana had a net margin of 1.28% and a return on equity of 13.67%. The business had revenue of $32.39 billion during the quarter, compared to analysts’ expectations of $31.85 billion. During the same quarter in the prior year, the firm posted $6.96 earnings per share. The firm’s quarterly revenue was up 9.6% on a year-over-year basis. Humana has set its FY 2025 guidance at 17.000- EPS. On average, analysts predict that Humana Inc. will post 16.47 earnings per share for the current year.

Humana Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Stockholders of record on Friday, September 26th will be given a dividend of $0.885 per share. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.2%. The ex-dividend date is Friday, September 26th. Humana’s payout ratio is 27.17%.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.